v3.26.1
Acquisition of Faeth and Pipe Issuance - Summary of Allocation of Estimated Fair Value of Consideration Transferred to Net Assets Acquired (Details) - Faeth Therapeutics
$ in Thousands
Feb. 17, 2026
USD ($)
Assets acquired:  
Cash and cash equivalents $ 6,464
Prepaid expenses 11,487
Other current assets 554
Property and equipment, net 10
Other non-current assets 412
Total assets acquired 18,927
Liabilities assumed:  
Accounts payable and accrued liabilities 5,844
Compensation and employee benefits liabilities 204
Total liabilities assumed 6,048
Net assets acquired 12,879
In process research and development 132,957
Total consideration transferred $ 145,836